Eblasakimab Shows Benefit in Atopic Dermatitis Among Dupilum

Eblasakimab shows promising itch relief in dupilumab-experienced atopic dermatitis patients, with significant reductions in symptoms observed.

Related Keywords

, Carl Firth , Stewartj Dupixent , Aslan Pharmaceuticals , Venereology Congress , European Academy Of Dermatology , Eczema Area Severity Index , Validated Investigator Global Assessment , European Academy ,